GLATIX-M-80 Tablets

Controlling Diabetes to Prevent CVD

 

COMPOSITION

Gliclazide 80 mg

INDICATION
  • Type 2 Diabetes
  • Cardiovascular Disorders

 GLATIX-M-80 Tablets

  • Sulfonylurea/ SUs (insulin secretagogues)
  • The experts opined that among the SUs, gliclazide provides effective glycemic control, has a low risk of hypoglycemia, does not cause weight gain, has renal safety, and provides treatment durability.
  • Inhibits the increased adhesiveness of Diabetic monocytes to endothelial cells & reduces the production of TNF-alpha.
  • Regarded as a novel carrier in the construction of PVC-based La (III)-selective membrane.
  • Improved glycemic control and aids in the prevention of both microvascular & macrovascular complications.
  • Safe and potent drug especially in patients with Ischemic heart disease.